The mRNA levels of SREBP1c downstream lipogenesis genes including FAS, SCD1, and ACC were enhanced by 2-AG treatment, which were efficiently reversed by GN treatment (Figure 4B). This evidence concerns the gene FAS and ganglioneuroma.